Vaishnaw Akshay

President of R&D at SRRK; Officer at ALNY

Sold, on record
$57.3M
Dollars the filings state
Form 4 sales
35
Latest Apr 16, 2026
Form 144 notices
2
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • SRRKScholar Rock Holding CorpPresident of R&D
  • ALNYALNYLAM PHARMACEUTICALS, INC.Officer

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ALNYUnusual
    Feb 10, 2023 2023

    Sold 38,044 shares at $215.97 ($8.2M)

    Vaishnaw Akshay, President

    Sold 71.8% of holdings ($11.4M position)14,970 shares left4.4x usual sizeFiling

  2. 2 Form 4 sale ALNYNo plan
    Apr 27, 2023 +76 days

    Sold 2,392 shares at $194.59 ($465k)

    Vaishnaw Akshay, President

    No 10b5-1 planSold 11.8% of holdings ($3.9M position)17,890 shares left0.2x usual sizeFiling

  3. 3 Form 4 sale ALNYNo plan
    Aug 4, 2023 +99 days

    Sold 4,057 shares at $185.85 ($754k)

    Vaishnaw Akshay, President

    No 10b5-1 planSold 15.1% of holdings ($5M position)22,774 shares left0.6x usual sizeFiling

  4. 4 Form 144 notice ALNYNotice
    Dec 11, 2023 +129 days

    Filed to sell 10,832 shares ($1.8M)

    Vaishnaw Akshay, Officer

    10b5-1 plan3.1x usual sizeFiling

  5. 5 Form 144 notice SRRKNotice
    May 29, 2025 +535 days

    Filed to sell 6,750 shares ($200k)

    Vaishnaw Akshay, Director

    10b5-1 planFirst sale on recordFiling

  6. 6 Form 4 sale SRRKRoutine
    May 29, 2025 same day

    Sold 6,750 shares at $29.72 ($201k)

    Vaishnaw Akshay, President of R&D

    10b5-1 planSold 1.1% of holdings ($18.5M position)616,205 shares leftFirst sale on recordFollows a Form 144Filing

  7. 7 Form 4 sale SRRKNo plan
    Jan 13, 2026 +229 days

    Sold 20,438 shares at $42.70 ($873k)

    Vaishnaw Akshay, President of R&D

    No 10b5-1 planSold 3.3% of holdings ($26.3M position)595,767 shares leftFiling

  8. 8 Form 4 sale SRRKNo plan
    Apr 16, 2026 +93 days

    Sold 12,246 shares at $49.57 ($607k)

    Vaishnaw Akshay, President of R&D

    No 10b5-1 planSold 1.9% of holdings ($31.9M position)630,542 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (37)

Form 144 notices and Form 4 sales by Vaishnaw Akshay
Source
Apr 16, 2026Apr 20, 2026SRRKPresident of R&DForm 4 sale12,246$607k1.9%No planSEC
Jan 13, 2026Jan 15, 2026SRRKPresident of R&DForm 4 sale20,438$873k3.3%No planSEC
May 29, 2025May 30, 2025SRRKPresident of R&DForm 4 sale6,750$201k1.1%RoutineSEC
May 29, 2025May 29, 2025SRRKDirectorForm 144 notice6,750$200kNoticeSEC
Dec 11, 2023Dec 11, 2023ALNYOfficerForm 144 notice10,832$1.8MNoticeSEC
Aug 4, 2023Aug 7, 2023ALNYPresidentForm 4 sale4,057$754k15.1%No planSEC
Apr 27, 2023Apr 28, 2023ALNYPresidentForm 4 sale2,392$465k11.8%No planSEC
Feb 10, 2023Feb 14, 2023ALNYPresidentForm 4 sale38,044$8.2M71.8%UnusualSEC
Dec 23, 2021Dec 23, 2021ALNYPresident, R&DForm 4 sale2,879$550k20.4%Plan not statedSEC
Aug 9, 2021Aug 11, 2021ALNYPresident, R&DForm 4 sale10,834$2.2M49.1%UnusualSEC
Jun 18, 2021Jun 22, 2021ALNYPresident, R&DForm 4 sale14,708$2.6M56.7%UnusualSEC
Apr 21, 2021Apr 21, 2021ALNYPresident, R&DForm 4 sale6,438$884k31.3%UnusualSEC
Sep 29, 2020Oct 1, 2020ALNYPresident, R&DForm 4 sale971$136k6.4%Plan not statedSEC
Jun 22, 2020Jun 24, 2020ALNYPresident, R&DForm 4 sale970$147k6.4%Plan not statedSEC
Apr 20, 2020Apr 22, 2020ALNYPresident, R&DForm 4 sale21,971$3.1M60.9%UnusualSEC
Feb 7, 2020Feb 11, 2020ALNYPresident, R&DForm 4 sale23,708$3M67.9%UnusualSEC
Mar 14, 2018Mar 16, 2018ALNYPresident, R&DForm 4 sale88,554$12.7M88.8%UnusualSEC
Oct 30, 2017Nov 1, 2017ALNYEVP, R&DForm 4 sale33,666$4.1M74.5%UnusualSEC
May 23, 2017May 25, 2017ALNYEVP, R&DForm 4 sale11,000$825k51.7%UnusualSEC
May 15, 2017May 17, 2017ALNYSVP, R&DForm 4 sale43,750$2.8M80.9%UnusualSEC
Nov 30, 2016Dec 2, 2016ALNYEVP, R&D, CMOForm 4 sale29,165$1.3M83.5%UnusualSEC
Jun 16, 2015Jun 18, 2015ALNYEVP, R&D, CMOForm 4 sale8,750$1.1M100.0%UnusualSEC
Mar 17, 2015Mar 19, 2015ALNYEVP, R&D, CMOForm 4 sale8,750$1M100.0%UnusualSEC
Dec 16, 2014Dec 16, 2014ALNYEVP, Chief Medical OfficerForm 4 sale10,626$995k100.0%UnusualSEC
Sep 16, 2014Sep 17, 2014ALNYEVP, Chief Medical OfficerForm 4 sale10,625$766k100.0%UnusualSEC
Jun 17, 2014Jun 19, 2014ALNYEVP, Chief Medical OfficerForm 4 sale10,625$742k100.0%UnusualSEC
Mar 18, 2014Mar 20, 2014ALNYEVP, Chief Medical OfficerForm 4 sale32,769$2.4M100.0%UnusualSEC
Jan 24, 2014Jan 27, 2014ALNYEVP, Chief Medical OfficerForm 4 sale7,890$677k100.0%UnusualSEC
Dec 17, 2013Dec 18, 2013ALNYEVP, Chief Medical OfficerForm 4 sale33,480$2M72.7%UnusualSEC
Sep 10, 2013Sep 12, 2013ALNYEVP, Chief Medical OfficerForm 4 sale6,250$359k33.2%UnusualSEC
Jun 11, 2013Jun 13, 2013ALNYEVP, Chief Medical OfficerForm 4 sale15,000$466k54.4%UnusualSEC
Mar 11, 2013Mar 11, 2013ALNYEVP, Chief Medical OfficerForm 4 sale6,250$153k33.2%UnusualSEC
Dec 12, 2012Dec 12, 2012ALNYEVP, Chief Medical OfficerForm 4 sale14,777$271k54.0%UnusualSEC
Dec 4, 2012Dec 6, 2012ALNYEVP, Chief Medical OfficerForm 4 sale2,400$41k16.0%Plan not statedSEC
Nov 30, 2012Dec 4, 2012ALNYEVP, Chief Medical OfficerForm 4 sale2,823$48k18.3%Plan not statedSEC
Sep 12, 2012Sep 12, 2012ALNYEVP, Chief Medical OfficerForm 4 sale6,250$119k33.2%UnusualSEC
Jul 16, 2012Jul 18, 2012ALNYSVP, Chief Medical OfficerForm 4 sale36,250$689k74.2%UnusualSEC